Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Tesamorelin Nasal Spray 10ml, 20mg

Tesamorelin Nasal Spray is studied hormone production support and visceral fat reduction. 20mg, 10ml bottle with certified research lab testing.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Tesamorelin Nasal Spray

Synthetic GHRH analog nasal spray, 20mg total, 80 sprays at 250mcg per spray.

Tesamorelin · 20mg total per bottle

250 mcg · 80 sprays/bottle · 10mL bottle · 96.184% purity

96.184% purity (HPLC)

Third-party tested · Freedom Diagnostics

Identity confirmed

Tested by Freedom Diagnostics · 04/12/2026

Key Ingredients

A 44-amino acid synthetic GHRH analogue with enhanced stability. Research documents pituitary somatotroph activation and growth hormone release through the GHRH receptor pathway.

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). It consists of the 44-amino-acid sequence of human GHRH with an additional trans-3-hexenoic acid modification at the N-terminus, which enhances its stability and bioactivity.

Research Background

Tesamorelin stimulates growth hormone release from the anterior pituitary via the GHRH receptor. Clinical research has studied its effects on visceral adipose tissue reduction and the GH/IGF-1 axis. The nasal spray format enables research into intranasal delivery of large peptide analogs. For research purposes only.

Tesamorelin

250 mcg per spray

Inactive ingredients / formulation base

Normal Saline (pH 6.0)

Base solution

Benzalkonium Chloride (BKC)

0.01% preservative

Lab-Grade Distilled Water

QS

SKU: TEN0020MG

Shipping: Orders ship within 1–2 business days. Free shipping on orders $100+. Delivery typically 1–3 business days.

Storage: Store in a cool, dry place. Refrigeration recommended after opening for optimal stability. Keep away from direct sunlight.

GHRH Analogue

Synthetic GHRH analogue for growth hormone axis research

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoic acid modification. It stimulates pituitary somatotroph cells to produce and release growth hormone through the GHRH receptor.

Published Research Data

Quantified findings from peer-reviewed studies on Tesamorelin

amino acid residues in the Tesamorelin peptide sequence

Falutz et al., N Engl J Med 2007 ↗

verified purity by HPLC analysis in every Stemcode batch

Stemcode Peptides COA data

Published Research

Studies on Tesamorelin

Randomized controlled trial documenting tesamorelin's effects on GH axis stimulation and metabolic parameters.

View all studies →

Why Research Peptides

All comparisons reflect general industry practices. Stemcode products are intended solely for laboratory research and are not for human consumption.

The Research Standard

Connected topics

Follow this recovery question